Definium Therapeutics DFTX
NASDAQ DFTX
$35.49 +0.40 (+1.14%)
At close: Oct 21, 2026 · 4:00 PM EDT

Definium Therapeutics (DFTX) Other Operating Expenses (2024 - 2025)

Updated

Definium Therapeutics (DFTX) posted Other Operating Expenses of -$35,000 for Q4 2025, compared with -$3,000 a year earlier.

Analysis

Definium Therapeutics (DFTX) Other Operating Expenses (2024 - 2025) Analysis & Trends

  • In prior years, Definium Therapeutics' Other Operating Expenses was -$3,000 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Definium Therapeutics 3.93 Bn 1.85 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -35,000.00
Dec 31, 2024 -3,000.00
API Access

Definium Therapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=DFTX&period=max&api_key=YOUR_API_KEY